Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras-Mutant Lung Cancers.

Talwelkar SS, Nagaraj AS, Devlin JR, Hemmes A, Potdar S, Kiss EA, Saharinen P, Salmenkivi K, Mäyränpää MI, Wennerberg K, Verschuren EW.

Mol Cancer Ther. 2019 Oct;18(10):1863-1874. doi: 10.1158/1535-7163.MCT-18-0573. Epub 2019 Jul 18.

PMID:
31320402
2.

Targeting β1-integrin inhibits vascular leakage in endotoxemia.

Hakanpaa L, Kiss EA, Jacquemet G, Miinalainen I, Lerche M, Guzmán C, Mervaala E, Eklund L, Ivaska J, Saharinen P.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):E6467-E6476. doi: 10.1073/pnas.1722317115. Epub 2018 Jun 25.

3.

Card9-dependent IL-1β regulates IL-22 production from group 3 innate lymphoid cells and promotes colitis-associated cancer.

Bergmann H, Roth S, Pechloff K, Kiss EA, Kuhn S, Heikenwälder M, Diefenbach A, Greten FR, Ruland J.

Eur J Immunol. 2017 Aug;47(8):1342-1353. doi: 10.1002/eji.201646765. Epub 2017 Jul 4.

4.

Pediatric skin integrity practice guideline for institutional use: a quality improvement project.

Kiss EA, Heiler M.

J Pediatr Nurs. 2014 Jul-Aug;29(4):362-7. doi: 10.1016/j.pedn.2014.01.012. Epub 2014 Feb 7. Review.

PMID:
24582648
5.

T-bet and Gata3 in controlling type 1 and type 2 immunity mediated by innate lymphoid cells.

Hoyler T, Connor CA, Kiss EA, Diefenbach A.

Curr Opin Immunol. 2013 Apr;25(2):139-47. doi: 10.1016/j.coi.2013.02.007. Epub 2013 Mar 13. Review.

PMID:
23490163
6.

A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.

Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d'Hargues Y, Göppert N, Croxford AL, Waisman A, Tanriver Y, Diefenbach A.

Nature. 2013 Feb 14;494(7436):261-5. doi: 10.1038/nature11813. Epub 2013 Jan 16.

PMID:
23334414
7.

Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22.

Raifer H, Mahiny AJ, Bollig N, Petermann F, Hellhund A, Kellner K, Guralnik A, Reinhard K, Bothur E, Huber M, Bauer S, Löhning M, Kiss EA, Ganal SC, Diefenbach A, Korn T, Lohoff M.

Eur J Immunol. 2012 Dec;42(12):3189-201. doi: 10.1002/eji.201142155. Epub 2012 Oct 17.

8.

Aryl hydrocarbon receptor: a molecular link between postnatal lymphoid follicle formation and diet.

Kiss EA, Vonarbourg C.

Gut Microbes. 2012 Nov-Dec;3(6):577-82. doi: 10.4161/gmic.21865. Epub 2012 Aug 22. Review.

9.
10.

Transcriptional control of innate lymphocyte fate decisions.

Klose CS, Hoyler T, Kiss EA, Tanriver Y, Diefenbach A.

Curr Opin Immunol. 2012 Jun;24(3):290-6. doi: 10.1016/j.coi.2012.04.004. Epub 2012 May 15. Review.

PMID:
22595694
11.

Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles.

Kiss EA, Vonarbourg C, Kopfmann S, Hobeika E, Finke D, Esser C, Diefenbach A.

Science. 2011 Dec 16;334(6062):1561-5. doi: 10.1126/science.1214914. Epub 2011 Oct 27.

12.

Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer.

Aalto K, Autio A, Kiss EA, Elima K, Nymalm Y, Veres TZ, Marttila-Ichihara F, Elovaara H, Saanijoki T, Crocker PR, Maksimow M, Bligt E, Salminen TA, Salmi M, Roivainen A, Jalkanen S.

Blood. 2011 Sep 29;118(13):3725-33. doi: 10.1182/blood-2010-09-311076. Epub 2011 Aug 5.

13.

Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes.

Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M, Bengsch B, Thimme R, Hölscher C, Hönig M, Pannicke U, Schwarz K, Ware CF, Finke D, Diefenbach A.

Immunity. 2010 Nov 24;33(5):736-51. doi: 10.1016/j.immuni.2010.10.017.

Supplemental Content

Support Center